Alvotech (ALVO) Change in Inventory (2021 - 2026)
Alvotech (ALVO) posted Change in Inventory of -$11.0 million for Q1 2026, down 158.81% on a QoQ basis from -$4.3 million in Q4 2025, and up 25.9% year-over-year from -$8.8 million in Q1 2025.
Alvotech (ALVO) Change in Inventory (2021 - 2026) Analysis & Trends
Alvotech's Change in Inventory history runs 6 years deep, the most recent figure standing at -$11.0 million for Q1 2026.
- Quarterly Change in Inventory rose 25.9% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$86.3 million (up 13.26% YoY) and the FY2025 annual result came in at -$90.1 million, down 80.36% from the prior year.
- Change in Inventory was -$11.0 million for Q1 2026 at Alvotech, down from -$4.3 million in the prior quarter.
- Across five years, Change in Inventory topped out at -$2.8 million in Q2 2024 and bottomed at -$53.0 million in Q3 2025.
- A 5-year average of -$17.7 million and a median of -$11.3 million in 2023 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 91.48% in 2025, while the deepest fall reached 546.1% in 2025.
- Alvotech's Change in Inventory stood at -$32.4 million in 2022, then surged by 65.12% to -$11.3 million in 2023, then plunged by 342.08% to -$50.0 million in 2024, then soared by 91.48% to -$4.3 million in 2025, then tumbled by 158.81% to -$11.0 million in 2026.
- Business Quant data shows ALVO's Change in Inventory at -$11.0 million in Q1 2026, -$4.3 million in Q4 2025, and -$53.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 40.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Alvotech | 907.91 Mn | 907.91 Mn | 5.09 Mn | -11.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.02 Mn |
| Mar 31, 2026 | -11.02 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Sep 30, 2025 | -53.03 Mn |
| Sep 30, 2025 | -53.03 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Mar 31, 2025 | -14.87 Mn |
| Mar 31, 2025 | -14.87 Mn |
| Dec 31, 2024 | -49.97 Mn |
| Dec 31, 2024 | -49.97 Mn |
| Sep 30, 2024 | -31.85 Mn |
| Sep 30, 2024 | -31.85 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Mar 31, 2024 | -12.42 Mn |
| Mar 31, 2024 | -12.42 Mn |
| Dec 31, 2023 | -11.30 Mn |
| Dec 31, 2023 | -11.30 Mn |